Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Donald Mcleod is active.

Publication


Featured researches published by Donald Mcleod.


Bioorganic & Medicinal Chemistry Letters | 1991

Phosphonamidates and phosphonamidate esters as HIV-1 protease inhibitors

Donald Mcleod; Ross I. Brinkworth; Jon A. Ashley; Kim D. Janda; Peter Wirsching

Simple dipeptides incorporating phosphonamidate and phosphonamidate ester isosteres for the scissile peptide bond are modest inhibitors of the HIV-1 protease. Their synthesis and inhibition studies are described.


Bioorganic & Medicinal Chemistry Letters | 2012

Discovery and characterization of AZD9272 and AZD6538—Two novel mGluR5 negative allosteric modulators selected for clinical development

Patrick Raboisson; Anna Breitholtz-Emanuelsson; Henrik Dahllöf; Louise Edwards; William L. Heaton; Methvin Isaac; Keith Jarvie; Annika Kers; Alexander Minidis; Anna Nordmark; Susan M. Sheehan; Abdelmalik Slassi; Peter Ström; Ylva Terelius; David Wensbo; Julie Wilson; Tao Xin; Donald Mcleod

AZD9272 and AZD6538 are two novel mGluR5 negative allosteric modulators selected for further clinical development. An initial high-throughput screening revealed leads with promising profiles, which were further optimized by minor, yet indispensable, structural modifications to bring forth these drug candidates. Advantageously, both compounds may be synthesized in as little as one step. Both are highly potent and selective for the human as well as the rat mGluR5 where they interact at the same binding site than MPEP. They are orally available, allow for long interval administration due to a high metabolic stability and long half-lives in rats and permeate the blood brain barrier to a high extent. AZD9272 has progressed into phase I clinical studies.


Tetrahedron | 1991

Substrate attenuation : an approach to improve antibody catalysis

Kim D. Janda; Stephen J. Benkovic; Donald Mcleod; Diane M. Schloeder; Richard A. Lerner

Abstract Antibodies raised to quinaldine phosphonamide 1a showed no ability to hydrolyze its most homologous substrates amide and ester 2 and 3, respectively. However, within this same set of antibodies some thirteen showed a great propensity to hydrolyse a structurally similar naphthyl ester. In addition to heteroatom discrimination one of the antibodies examined in detail displayed an increase in catalytic efficiency presumably via weak apparent binding (Km) when phenylesters were employed as substrates. These findings suggest abzyme catalysis may be improved via substrate attenuation. Antibodies raised to quinaldine phosphonamide 1a showed no ability to hydrolyze its most homologous substrates amide and ester 2 and 3, respectively. However, within this same set of antibodies some thirteen showed a great propensity to hydrolyse a structurally similar naphthyl ester. In addition to heteroatom discrimination one of the antibodies examined in detail displayed an increase in catalytic efficiency presumably via weak apparent binding (Km) when phenylesters were employed as substrates. These findings suggest abzyme catalysis may be improved via substrate attenuation.


Faraday Symposia of The Chemical Society | 1980

Electron spin resonance study of intermetallic molecules cum and aum (M = Mg, Zn, Cd and Hg)

Paul H. Kasai; Donald Mcleod

A series of intermetallic diatomic molecules, CuM and AuM (M = Mg, Zn, Cd and Hg) generated in argon matrices was examined by e.s.r. spectroscopy. For all the CuM and AuM examined, the hyperfine coupling tensors to the Cu and Au nuclei were isotropic. The unpaired electron resides in an orbital given essentially by an antibonding combination of the valence s orbitals of Cu (or Au) and M atoms. Coupling interactions observed with magnetic Cd and Hg nuclei, and the analysis of the g tensor indicate a small admixture (≈ 10%) of the valence pz orbital of the atom M in each CuM and AuM examined.


Archive | 2005

Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

Bradford Van Wagenen; Thomas M. Stormann; Scott T. Moe; Susan M. Sheehan; Donald Mcleod; Daryl L. Smith; Methvin Isaac; Abdelmalik Slassi


Biotechnology Progress | 1991

Evaluation of immunoglobulins from plant cells.

Mich B. Hein; Ying Tang; Donald Mcleod; Kim D. Janda; Andrew C. Hiatt


Journal of the American Chemical Society | 1990

Immobilized catalytic antibodies in aqueous and organic solvents

Kim D. Janda; Jon A. Ashley; Teresa M. Jones; Donald Mcleod; Diane M. Schloeder; Michael I. Weinhouse


Archive | 2003

'1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5

David Wensbo; Tao Xin; Tomislav Stefanac; Jalaj Arora; Louise Edwards; Methvin Isaac; Abdelmalik Slassi; Thomas M. Stormann; Donald Mcleod; Annika Kers; Johan Malmberg; Karin Oscarsson; Helena Gyback; Martin Johansson; Alexander Minidis; Magnus Waldman; Ulrika Yngve; Christoffer Osterwall


Journal of the American Chemical Society | 1991

Catalytic antibodies with acyl-transfer capabilities: mechanistic and kinetic investigations.

Kim D. Janda; J.A. Ashley; T.M. Jones; Donald Mcleod; Diane M. Schloeder; M.I. Weinhouse; Richard A. Lerner; R.A. Gibbs; P.A. Benkovic; R. Hilhorst; S.J. Benkovic


Journal of the American Chemical Society | 1967

Flash vacuum pyrolysis. II. Electronic, vibrational, and electron spin resonance spectra of the benzyl radical

Charles L. Angell; E. Hedaya; Donald Mcleod

Collaboration


Dive into the Donald Mcleod's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Louise Edwards

University Health Network

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge